(877) 505-4777| info@speakersnetwork.com

Cardiology, Cardiothoracic & Cardiovascular Surgery


Endowed Chair of Preventive Cardiology
Program Director, Division of Cardiology
Professor of Medicine


Cardiac Computed Tomography
Aggressive Lipid Therapies: New NCEP Guidelines
Hypertension: New Studies, Old Disease
The ABCs of Primary Prevention
Screening for Heart Disease
Women and Cardiovascular Disease
CT Angiography
New Insights into Hypertensive Therapies
Healthy Kidneys, Healthy Heart: Reducing Cardiovascular Risks in Patients with Chronic Kidney Disease
Controversies in the Use of Aspirin for Primary Prevention
Treatment of Elevated Lipids in Patients Intolerant of Statins
Update on Statins and Guidelines

Testimonials: Excellent presentation and speaker! – Citrus Valley Medical Center We liked him! – SEIU-UHW West
State: CA

Chief, Cardiology Division
Medstar Heart and Vascular Institute
Professor of Medicine
Georgetown University


Acute Coronary Syndrome
Cardiovascular Prevention
Cardiovascular Risk Assessment

State: DC

Assistant Professor of Medicine
Division of Cardiovascular Medicine
University of Maryland School of Medicine


Acute Myocardial Infarction
Renal Denervation
Transcatheter Aortic Valve Replacement
Appropriate Use Criteria and Percutaneous
Radial Cath: Starting a New Program
Ask a Cardiologist a Question – Most Common Questions Asked of a Cardiologist

State: md

Professor of Medicine
Georgetown University School of Medicine


Improving Outcomes in Acute Coronary Syndrome
Concepts and Controversies in Unstable Angina and Myocardial Infarction
Team Management in Acute Myocardial Infarction

Biography: Charles E. Rackley received his MD Degree from Duke University in 1958. Residency in Internal Medicine was at Duke and the University of Washington in Seattle. Cardiology Fellowships followed at the University of Washington and at Duke. He then served on the Faculty at the Department of Medicine at the University of North Carolina and later at the University of Alabama in Birmingham. In Birmingham, he was Director of the Myocardial Infarction Research Unit followed by Director of the Specialized Center Research for Ischemic Heart Disease. In 1982, he was appointed Chairman of the Department of Medicine at Georgetown University Medical Center, and in 1988 became the Director of Lipid Disorder Center. He has served on editorial Boards of ten Cardiovascular Journals, Chairman of the NIH Cardiovascular Renal Study Section, and the Cardiovascular Advisory Committee for the National Heart, Lung and Blood Institute. He was President of the Southern Society for Clinical Investigation and also a member of the American Society for Clinical Investigation, American College of Cardiology and the American Heart Association. He has published 22 books and 367 scientific publications. He currently serves on the Task Force for Hormonal Replacement Therapy and Coronary Heart Disease for the American College of Obstetrics and Gynecology.
State: dc

Professor of Medicine


Etiology and Treatment of Diabetic Complications; New Drugs and New Hopes
Cardiovascular and Renal Benefits of New Diabetic Treatments
Hypertension Update: New Guidelines
Update of ACC/AHA Blood Cholesterol Guidelines
Use of Continuous Glucose Monitoring
Preventing Diabetes- Does Receiving Texts or Other Methods Really Prevent Diabetes?
Cholesterol and Alzheimer’s Disease
Antipsychotics: Benefits, Risks and a Common Side Effect: Diabetes
Vitamin D Deficiency
Pre-Operative Evaluations: New Guidelines and What May or May Not Save Lives
Osteoporosis Update and New Treatments
Type 1 Diabetes: Update and Potential New Treatments
Treatments for Obesity
Treatment of Type 2 Diabetes Mellitus
Hypercholesterolemia: New Treatment Guidelines
Insulin Resistance: The Core of Type 2 Diabetes
How to Survive Your Hospital Admission
Current Advances in Nutritional Support
Lipids: The Good, The Bad and The Unknown
New Treatment for Coronary Artery Disease
Thyroid Disease Update
Ethnicity, Diabetes and New Treatment Options
Nutritional Support / TPN
Diabetic Neuropathy: New Treatment of What Works
Diabetic Neuropathy: Prevention, ESRD and Cardiovascular Disease
Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease in Children
Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease in Adults
The Increase in Metabolic Syndrome Seen in Pediatrics and New Treatment Options
Metabolic Syndrome Can be Seen in 20% of Adults; Review and New Treatment Options
Outpatient Clinical Nutrition Pearls for Pediatrics
Outpatient Clinical Nutrition Pearls; Risk and Benefits in Adults
Nutrition and Cancer Prevention
How to Outlive Your Parents
DM1 Review and New Treatment Options in Pediatrics
DM2 Review and New Treatment Options in Pediatrics
Hyperlipidemia in Children: When to Screen, Treat and Worry about Your Child


Director, Womens Cardiovascular Program
Medstar Heart Institute
Professor of Medicine,
Division of Cardiology
Georgetown University Hospital


Heart Disease in Women
Cardiovascular Disease in HIV Patients
Lipid Guidelines Update
Heart Disease
Acute Myocardial Infarction

State: dc

Associate Professor of Medicine, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medical College


Peri-procedural PCI Antiplatelet Therapy
Peripheral Arterial Disease: Endovascular Therapy
Stent Thrombosis in Current DES Era
Renal Artery Disease
Renal Denervation Therapy
Platelet Inhibition and Platelet Function Testing
Carotid Artery Disease and Carotid Stenting

Biography: Dr. Dmitriy N. Feldman is the Director of Endovascular Service of Interventional Cardiac and Endovascular Laboratory in the Division of Cardiology. He graduated Summa Cum Laude from New York University in December 1996 and received his Doctorate of Medicine degree from the Mount Sinai School of Medicine May 2001 in New York City. He completed his medical internship, residency in Internal Medicine, fellowship in Clinical Cardiology, and Interventional Cardiology Fellowship training at New York Presbyterian Hospital, Weill Cornell Medical College in New York City. He is board certified in Internal Medicine, Cardiovascular Disease, Interventional Cardiology and Endovascular Medicine.Dmitriy N. Feldman, M.D. is an Interventional Cardiologist specializing in angioplasty and stenting and one of Cornells leaders in management of cardiovascular and peripheral vascular diseases on both inpatient and outpatient basis. His clinical expertise extends from the performance of complex coronary interventions to endovascular treatment of peripheral and carotid disease. His areas of research interest include percutaneous coronary and endovascular intervention outcomes research and he has performed extensive work with the New York State Department of Health PCI database, American College of Cardiology National Cardiovascular Data Registry as well as the Cornell Catheterization Laboratory institutional database. His area of research expertise includes the use of peri-procedural pharmacological agents, particularly bivalirudin, glycoprotein IIb/IIIa inhibitors, and thienopyridines. Dr. Feldmans research activities have been published in high impact journals such as Circulation, the Journal of American College of Cardiology, American Heart Journal, American Journal of Cardiology, and he has presented his findings at numerous national meetings including American Heart Association, American College of Cardiology, and Transcatheter Cardiovascular Therapeutics. He also serves as a peer reviewer for major high-impact medical journals such as Circulation, the LANCET and others.Dmitriy N. Feldman, MD is a member of multiple professional societies: Fellow of American College of Cardiology (FACC), Fellow of Society for Cardiovascular Angiography and Interventions (FSCAI), Member of American Heart Association, Doctorate of Society for Vascular Medicine. He serves on Society for Cardiovascular Angiography and Interventions (SCAI) PVD committee and has been a passionate advocate in emphasizing importance of PVD and endovascular therapies. He has participated in writing consensus/expert documents with SCAI and ACC in the fields of coronary and peripheral vascular disease. Dr. Feldman has served as a principal investigator and coinvestigator on numerous trials and registries in coronary, structural heart, peripheral vascular and carotid disease areas of research. Dr. Feldman is one of Cornells leaders in managing patients with resistant/refractory hypertension and evaluating novel percutaneous renal denervation therapy for those patients. He serves as a member of the Institutional Protocol Review Committee for Therapeutic and Interventional Studies and member of Vascular Service Line, Peripheral Intervention Quality Committee.Dr. Feldman is currently appointed as a Director of Endovascular Cardiology Center for Vascular Care, an Assistant Professor of Medicine and an Assistant Attending Physician in the Interventional Cardiac and Endovascular Laboratory of the Greenberg Division of Cardiology.
State: ny

Director, Cardiac Catheterization Laboratories & Interventional Cardiology
Robert Packer Hospital & Guthrie Health Services
Professor of Medicine, New Jersey Medical School


Treatment of Acute and Chronic Heart Failure
Interventional Cardiology
Acute Coronary Syndromes
ST Elevation MI
Cardiogenic Shock
Invasive Hemodynamic Monitoring
Pulmonary Embolism
Preventive Cardiology
Treatment of Hypertension
Antiplatelet Agents
Anticoagulation and Especially New Oral Anticoagulants
Atrial Fibrillation and Flutter: Contemporary Strategies
Risk Stratification & Cardiac Clearance for Non-Cardiac Surgery
Sudden Cardiac Death
Fractional Flow Reserve
Primary PCI
Aortic Stenosis

Testimonials: Dr. Kaluski was AWESOME! The audience loved his presentation. – United Medical CenterThe lecture on AF with Dr. Kaluski went very well – St. Josephs Family Medicine at Clifton
State: pa

Associate Chief, Cardiology
Professor of Internal Medicine
UC Davis School of Medicine


Chest Pain
Testing for Coronary Artery Disease
Mininvasive Testing for Coronary Artery Disease
Preventive Cardiology: Lipids, HTN, etc.
Congestive Heart Failure

State: CA

Director Cardiac EP Fellowship
Associate Professor of Medicine
University of Michigan Health System


Cardiac ELectrophysiology
Sudden Cardiac Death: Concepts, Interventions and Prevention
Implantable Defibrillators: Patient and Device Selection
Atrial Fibrillation: Current Guidelines and Emerging Treatments
Syncope: Diagnosis and Treatment
Starting and Sustaining a Successful ELectrophysiology Fellowship
End of Life Care for Patients with Implantable Cardiac Devices
The Role of Chronic Inflammation in Cardiac Disease
Serving as a Medical Expert Witness: Approaches and Process
Sudden Death and TASERs: What We Know and What We Dont Know

State: MI